• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Research

coronavirus Omicron
Posted inCOVID-19, Infections, Research

Omicron Treatment: Most Effective Drugs

August 31, 2022September 8, 2022

Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.

Monkeypox 2022. Full Review
Posted inInfections, Research

Monkeypox 2022. Full Review

June 1, 2022September 12, 2022

Monkeypox as a new threat to humanity.

Favipiravir to Treat COVID-19. Most Comprehensive Review in World
Posted inClinical Trials, COVID-19, Infections, Research

Favipiravir to Treat COVID-19. Most Comprehensive Review in World

March 5, 2022September 8, 2022

What benefit we should expect from favipiravir in the fight against coronavirus?

liver
Posted inOncology, Research

Tecentriq Plus Avastin: Most Effective Treatment for Unresectable Hepatocellular Carcinoma

January 30, 2022September 8, 2022

Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.

Paxlovid (nirmatrelvir + ritonavir).
Posted inCOVID-19, Infections, Research

Paxlovid Works Against Omicron

January 18, 2022September 8, 2022

The newest COVID-19 treatment is highly effective against the Omicron variant of SARS-CoV-2 coronavirus.

Eliminating Health Disparities Is Key to Ending Pandemic
Posted inCOVID-19, Infections, Research

Eliminating Health Disparities Is Key to Ending Pandemic

December 29, 2021September 8, 2022

Misinformation, populism, and self-interest keep the COVID-19 that has enslaved the planet.

coronavirus
Posted inCOVID-19, Infections, Research

Three Billion Omicron Cases

December 25, 2021September 8, 2022

Omicron, a new variant of the SARS-CoV-2 coronavirus, will infect nearly 40% of the world’s population.

Posts navigation

1 2 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News